Press release
Antifibrotic Drugs Market Worldwide Industry Analysis, Future Demand and Forecast till 2028
Antifibrotic drugs market is anticipated to grow at a significant CAGR during the forecast period. The key factor that is anticipated to drive the market growth includes the rising prevalence of idiopathic pulmonary fibrosis and the growing R&D activities. Idiopathic pulmonary fibrosis is a serious, though rare disease majorly affecting human lungs. It primarily leads to the building up of scar tissue within the lungs. This stiffens them as such where they fail to contract and expand. Talking about idiopathic pulmonary fibrosis, in the US alone about 30,000 to 40,000 new cases are found each year, as per the National Institutes of Health (NIH). Across the globe, the incidence of idiopathic pulmonary fibrosis is estimated to be 10.7 cases per 100,000 person-years for males and 7.4 cases per 100,000 person-years for females. The prevalence of idiopathic pulmonary fibrosis is estimated to be 20 cases per 100,000 persons for males and 13 cases per 100,000 persons for females.To Request a Sample of our Report on Antifibrotic Drugs Market: https://www.omrglobal.com/request-sample/antifibrotic-drugs-market
Some key players operating in the market include Boehringer Ingelheim GmbH, F. Hoffman La-Roche AG, and Bristol-Myers Squibb Company, among others. Further, Esbriet, an oral pirfenidone approved for the treatment of idiopathic pulmonary fibrosis and is available in around 40 countries globally received the Orphan Drug Designation and was approved for use in Europe in 2011 in adults with mild-to-moderate idiopathic pulmonary fibrosis (and in the US in people with idiopathic pulmonary fibrosis in October 2014).
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered
Regions Covered- Globally
Competitive Landscape: Boehringer Ingelheim GmbH, F. Hoffman La-Roche AG, and Bristol-Myers Squibb Company, among others.
Antifibrotic Drugs Market by Segmentation
By Type
Oral
Injectable
Topical
By Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
A full Report of Antifibrotic Drugs Market is Available at: https://www.omrglobal.com/industry-reports/antifibrotic-drugs-market
Antifibrotic Drugs Market by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
https://citytoday-hildesheim.de/index.php/2022/12/24/der-syngas-und-terminmarkt-wird-bis-2028-eine-robuste-expansion-erleben/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ec%84%b1%ec%9e%a5-%ea%b0%80%ec%86%8d%ed%99%94%eb%a5%bc-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-%ea%b2%b8%ec%83%81-%ec%a0%81%ed%98%88%ea%b5%ac-%ec%a7%88%ed%99%98-%ec%95%bd/199979/
https://sportmsr.com/%d8%b3%d9%88%d9%82-%d8%a7%d9%84%d8%a3%d8%af%d9%88%d9%8a%d8%a9-%d8%a7%d9%84%d9%86%d8%a8%d8%a7%d8%aa%d9%8a%d8%a9-%d9%88%d8%a7%d9%84%d9%85%d8%b4%d8%aa%d9%82%d8%a9-%d9%85%d9%86-%d8%a7%d9%84%d9%86%d8%a8/
https://revistaeconomiasocial.com/2022/12/24/valor-de-mercado-de-camiones-comerciales-electricos-proyectado-para-expandirse-para-2028/
https://www.diario-ya.com/regionales/cubesat-%e5%b8%82%e5%a0%b4%e9%a0%90%e8%a8%88%e5%9c%a8%e9%a0%90%e6%b8%ac%e6%9c%9f%e5%85%a7%ef%bc%882022-%e5%b9%b4%e8%87%b3-2028-%e5%b9%b4%ef%bc%89%e4%bb%a5%e7%a9%a9%e5%ae%9a%e7%9a%84%e8%a4%87%e5%90%88/275163/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifibrotic Drugs Market Worldwide Industry Analysis, Future Demand and Forecast till 2028 here
News-ID: 2862242 • Views: …
More Releases from Orion Market Research

Eggshell Membrane Market Set to Witness Significant Growth by 2033 | Eggnovation …
The global Eggshell Membrane Market was valued at approximately USD 173.78 million in 2024, and is projected to reach USD 396.55 million by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2033.
Eggshell Membrane Market Overview
The Eggshell Membrane Market is experiencing significant growth, driven by increasing consumer awareness of its health benefits, particularly in joint health and skin care. This natural biopolymer, rich in proteins…

Printable Solar Cells Market Set to Witness Significant Growth by 2033 | Armor G …
The global Printable Solar Cells Market was valued at approximately USD 1.2 billion in 2024, and is projected to reach USD 4.8 billion by 2033, exhibiting a strong compound annual growth rate (CAGR) of 16.7% from 2025 to 2033.
Printable Solar Cells Market Overview
The Printable Solar Cells Market is on a rapid upward trajectory, led by rising demand for flexible, lightweight, and cost-effective energy solutions. Printable photovoltaic technologies-including organic, perovskite,…

Sales Enablement Software Market Size Analysis, Competitive Insights, Leading Pl …
The Sales Enablement Software Market was valued at approximately USD 3.4 billion in 2024 and is projected to reach around USD 13.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2033.
Sales Enablement Software Market Overview
The Sales Enablement Software Market is experiencing significant growth, driven by the increasing need for businesses to enhance their sales processes and improve team performance. These platforms…

Feed management software Market Set to Witness Significant Growth by 2033 | Prai …
The global Feed Management Software Market was estimated to be around USD 0.6 billion in 2024, and is projected to reach approximately USD 1.2 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Feed Management Software Market Overview
The Feed Management Software Market is expanding steadily as the agriculture and livestock industries shift toward digital transformation to optimize feed formulation and reduce…
More Releases for Antifibrotic
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025: Innovative Immunomod …
Bronchiolitis Obliterans Syndrome (BOS), a chronic and often irreversible manifestation of lung transplant rejection, remains a leading cause of morbidity and mortality in post-transplant patients. Characterized by progressive small airway inflammation and fibrosis, BOS significantly limits long-term graft survival despite advances in immunosuppressive regimens.
As of 2025, the BOS treatment pipeline is gaining renewed momentum, with over 3 assets under various stages of development. These include emerging antifibrotic agents, immune-targeting biologics,…
Liver Fibrosis Pipeline: 50+ Companies Advancing Antifibrotic Therapies and Dise …
The therapeutic landscape for liver fibrosis, a pathological scarring process resulting from chronic liver injury, is rapidly evolving, as biopharmaceutical innovators shift their focus from symptomatic control to targeting the fibrogenic mechanisms driving disease progression. With no FDA-approved treatments specifically for reversing liver fibrosis, the spotlight is now on antifibrotic agents, inflammation modulators, and regenerative therapies aimed at halting or reversing fibrotic damage before it advances to liver fibrosis. Companies…
Cirrhosis Pipeline: Novel Antifibrotic Therapies and Regenerative Approaches Red …
The treatment landscape for cirrhosis, a progressive liver condition marked by fibrosis and compromised liver function, is witnessing a transformative shift as biopharmaceutical companies advance beyond symptomatic management to target the underlying causes of liver damage. With no approved therapies to reverse established fibrosis, there is a growing focus on antifibrotic agents, hepatoprotective compounds, and regenerative therapies that aim to halt or reverse disease progression. Companies like Ocera Therapeutics, Gilead…
Antifibrotic Drugs Market - Current Impact to Make Big Changes by 2033
As of 2024, the global antifibrotic drugs market is estimated to be valued at approximately USD 1.4 billion. Looking ahead, the market is projected to reach around USD 2.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of 4.68% from 2025 to 2033.
Antifibrotic Drugs Market Overview
The global antifibrotic drugs market is experiencing significant growth, driven by the rising prevalence of fibrotic diseases such as idiopathic pulmonary fibrosis (IPF),…
Antifibrotic Drugs Market Share, Trends, Analysis and Forecast 2023-2029
The global antifibrotic drugs market is anticipated to grow at a significant CAGR during the forecast period. The key factor that is anticipated to drive the market growth includes the rising prevalence of idiopathic pulmonary fibrosis and the growing R&D activities. Idiopathic pulmonary fibrosis is a serious, though rare disease majorly affecting human lungs. It primarily leads to the building up of scar tissue within the lungs. This stiffens them…
Global Antifibrotic Drugs Market Comprehensive Insight by Growth Rate, Industry …
The global antifibrotic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The key factor that is anticipated to drive the market growth includes the rising prevalence of idiopathic pulmonary fibrosis and the growing R&D activities. Idiopathic pulmonary fibrosis is a serious, though rare disease majorly affecting human lungs. It primarily leads to the building up of scar tissue within the lungs. This stiffens…